Chase Hansen, MD
Radiation Oncology · Ogden, UTNPI 1265987945
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 71.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $228 and has fallen 53.9% since, to $105 in 2025.
Across 18 payments — averaging $42.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$544
- Varian Medical Systems, Inc.$104
- Teleflex LLC$42
- Bioprotect Medical, Inc.$23
- Pfizer$17
- Siemens Medical Solutions USA, Inc.$15
- plus $15 from 1 others
What the payments were for
- Food & beverage$760100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 11 | $544 |
| Varian Medical Systems, Inc. | 1 | $104 |
| Teleflex LLC | 2 | $42 |
| Bioprotect Medical, Inc. | 1 | $23 |
| Pfizer | 1 | $17 |
| Siemens Medical Solutions USA, Inc. | 1 | $15 |
| Medtec LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$760 in reported general payments places this provider in the 60th percentile of 49 radiation oncology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 96 | $1,800 |
| Bicalutamide | 31 | $1,004 |
| Methylprednisolone | 20 | $181 |
| Celecoxib | 15 | $179 |
| Ciprofloxacin Hcl | 13 | $98 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Ogden
- Jaden EvansOgden$884
- Gary WhippleOgden$807
- Roger HansenOgden$783
- Brandon FisherOgden$397
- Jonathan TwardSalt Lake City$114K
- David GaffneySalt Lake City$22K
- Brandon BarneyAmerican Fork$16K
- Douglas HoltSalt Lake City$3K
- Kristine KokenySalt Lake City$3K
- Matthew PoppeSalt Lake City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.